COMPARATIVE-STUDY OF THE EFFICACY OF KETOPROFEN ACCORDING TO THE ROUTE OF ADMINISTRATION (INTRAMUSCULAR OR ORAL) - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN PATIENTS WITH RHEUMATOID-ARTHRITIS

被引:0
|
作者
DOUGADOS, M
LISTRAT, V
DUCHESNE, L
AMOR, B
机构
来源
REVUE DU RHUMATISME | 1992年 / 59卷 / 11期
关键词
KETOPROFEN; RHEUMATOID ARTHRITIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evidence of the analgesic effects of nonsteroidal antiinflammatory drugs in human diseases is easy to collect. However, demonstration of differences in the activity of NSAIDs according to the route of administration is considerably more difficult. Forty patients with rheumatoid arthritis were given either one intramuscular injection of 100 mg ketoprofen with two placebo capsules or one intramuscular injection of placebo with two 50 mg ketoprofen capsules. Analysis of changes in pain severity over the six-hour study period failed to disclose any statistically significant differences between the two groups. However, time to peak effectiveness (Tmax) was significantly shorter with the intramuscular route (194 +/- 118 minutes) than with the oral route (276 +/- 111 minutes) (p = 0.029). Although intramuscular NSAID therapy is rarely warranted in RA patients, these findings suggest that RA may serve as a clinical model for evaluating the effectiveness of a NSAID according to the route of administration.
引用
收藏
页码:769 / 773
页数:5
相关论文
共 50 条
  • [31] Topical ketoprofen patch (100 mg) for the treatment of ankle sprain -: A randomized, double-blind, placebo-controlled study
    Mazières, B
    Rouanet, S
    Velicy, J
    Scarsi, C
    Reiner, V
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2005, 33 (04): : 515 - 523
  • [32] A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis-Related Arthritis
    Burgos-Vargas, Ruben
    Tse, Shirley M. L.
    Horneff, Gerd
    Pangan, Aileen L.
    Kalabic, Jasmina
    Goss, Sandra
    Unnebrink, Kristina
    Anderson, Jaclyn K.
    ARTHRITIS CARE & RESEARCH, 2015, 67 (11) : 1503 - 1512
  • [33] Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial
    Zamani, Batol
    Golkar, Hamid R.
    Farshbaf, Shima
    Emadi-Baygi, Modjtaba
    Tajabadi-Ebrahimi, Maryam
    Jafari, Parvaneh
    Akhavan, Reyhaneh
    Taghizadeh, Mohsen
    Memarzadeh, Mohammad R.
    Asemi, Zatollah
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (09) : 869 - 879
  • [34] THE EXPRESSION OF RHEUMATOID-ARTHRITIS IN MALAYSIAN AND BRITISH PATIENTS - A COMPARATIVE-STUDY
    VEERAPEN, K
    MANGAT, G
    WATT, I
    DIEPPE, P
    BRITISH JOURNAL OF RHEUMATOLOGY, 1993, 32 (07): : 541 - 545
  • [35] One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
    Genovese, Mark C.
    Durez, Patrick
    Richards, Hanno B.
    Supronik, Jerzy
    Dokoupilova, Eva
    Aelion, Jacob A.
    Lee, Sang-Heon
    Codding, Christine E.
    Kellner, Herbert
    Ikawa, Takashi
    Hugot, Sophie
    Ligozio, Gregory
    Mpofu, Shephard
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (03) : 414 - 421
  • [36] Safety and Efficacy of Various Dosages of Ocrelizumab in Japanese Patients with Rheumatoid Arthritis with an Inadequate Response to Methotrexate Therapy: A Placebo-controlled Double-blind Parallel-group Study
    Harigai, Masayoshi
    Tanaka, Yoshiya
    Maisawa, Shingo
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (03) : 486 - 495
  • [37] Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study
    Tanaka, Yoshiya
    Emoto, Kahaku
    Cai, Zhihong
    Aoki, Takehiro
    Schlichting, Douglas
    Rooney, Terence
    Macias, William
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (03) : 504 - 511
  • [38] Oral type II collagen in the treatment of rheumatoid arthritis. A six-month double blind placebo-controlled study
    Cazzola, M
    Antivalle, M
    Sarzi-Puttini, P
    Dell'Acqua, D
    Panni, B
    Caruso, I
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (05) : 571 - 578
  • [39] Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: A 12-week, multicenter, randomized, double-blind, placebo-controlled study
    Gibofsky, Allan
    Rodrigues, Jude
    Fiechtner, Justus
    Berger, Manuela
    Pan, Sharon
    CLINICAL THERAPEUTICS, 2007, 29 (06) : 1071 - 1085
  • [40] Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trial
    Fujieda, Yuichiro
    Horita, Tetsuya
    Nishimoto, Naoki
    Tanimura, Kazuhide
    Amasaki, Yoshiharu
    Kasahara, Hideki
    Furukawa, Shin
    Takeda, Tsuyoshi
    Fukaya, Shinji
    Matsui, Kazuo
    Tsutsumi, Akito
    Furusaki, Akira
    Sagawa, Akira
    Katayama, Kou
    Takeuchi, Kaoru
    Katsumata, Kazuaki
    Kurita, Takashi
    Shane, Peter
    Kato, Masaru
    Oku, Kenji
    Yasuda, Shinsuke
    Takahata, Masahiko
    Iwasaki, Norimasa
    Atsumi, Tatsuya
    MODERN RHEUMATOLOGY, 2021, 31 (03) : 593 - 599